Vitakey Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: low-cost compounded semaglutide or tirzepatide if you are fine prepaying for 3 months
Price is where Vitakey scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Vitakey is an online telehealth brand operated by Peptivo LLC that sells compounded semaglutide and tirzepatide, plus NAD+, glutathione, sermorelin and tesamorelin. Weight-loss medication is sold only as a 3-month supply paid upfront: semaglutide costs $279 or $415 and tirzepatide $515 or $605, depending on whether you choose the microdose or macrodose tier. Consultation and shipping are included.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Vitakey
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee compounded or brand-name GLP-1 injections
Editorial score · methodology
Oak
Best for: compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
Editorial score · methodology
Vitakey at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $93/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Vitakey
Each dimension is scored algorithmically from Vitakey’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.3/10At $93/mo, Vitakey runs about 48% below the $179 median for GLP-1 providers.
Effectiveness25%
7.3/10Vitakey offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.6/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
6.5/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.3/10Vitakey's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.1/10Vitakey provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Vitakey review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $93–$202/mo across 4 dose/plan tiers — checked October 2026
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Vitakey
We walked Vitakey’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Homepage treatment cards show compounded semaglutide and tirzepatide as a 3-month supply, with a Microdose or Macrodose toggle and the upfront total
- 2Get started opens a 20-step intake on app.vitakeywellness.com, run on the Fuse Health platform
- 3Step 1 asks you to accept a telehealth informed consent and privacy policy issued by Beluga Health
- 4The intake then covers medical history, pregnancy screening, body measurements, GLP-1 history and a photo ID upload
- 5Your state, account details and date of birth are collected late in the form, before a licensed provider reviews it in 24 to 48 hours
- Walked the public funnel only: no account was created, no health information was submitted, and we stopped at the step 1 consent checkbox. We have not taken the medication
- Prices are shown upfront, but GLP-1s come only as a 3-month supply billed at once: $279 or $415 for semaglutide, $515 or $605 for tirzepatide
- Both dose tiers send you to the same intake. The portal lists the semaglutide program as 'Flat Rate - $425', which doesn't match the $415 shown on the homepage
- The site's treatments page shows an older price set ($275 and $325 for semaglutide, $425 and $515 for tirzepatide), and its links return 'This program is not currently available'
- The intake asks for a photo of a government ID and lets you choose standard titration or microdosing
- The homepage's 'Dr. Emery replied 2 min ago' and '-16% body weight' bubbles are decorative graphics, not live data or a cited study
- Support is email and portal messaging, Monday to Friday, 8am to 5pm CT. Phone support is mentioned but no number is listed
Vitakey customer support
- Hours
- Monday-Friday, 8am-5pm CT
GLP-1 medications Vitakey offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Vitakey offers
Beyond GLP-1s, Vitakey also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
$279 charged upfront for a 3-month supply, about $93 a month. The site labels this tier 'Best for Maintenance & Starter Doses'. No 1-month option is offered.
$415 charged upfront for a 3-month supply, about $138 a month. The site labels this tier 'Best for Full Weight Loss'.
$515 charged upfront for a 3-month supply, about $172 a month. The site labels this tier 'Best for Maintenance & Starter Doses'.
$605 charged upfront for a 3-month supply, about $202 a month. The site labels this tier 'Best for Full Weight Loss'.
Ready to get started?
Plans and promotions change often — check Vitakey's current pricing and active discounts before you decide.
What we like
- Prices are on the homepage before any intake, including the full amount billed upfront
- Says consultation, prescription and express shipping are included, with no membership fee
- Per-month cost is low for compounded GLP-1s: about $93 to $138 for semaglutide and $172 to $202 for tirzepatide
- The site shows a LegitScript seal served from LegitScript's own seal server
- Written refund policy: full refund if medication hasn't shipped, and no medication charge if you aren't prescribed
- Names its operator, Peptivo LLC, and states that Texas law governs its terms
Watch-outs
- GLP-1s are sold only as a 3-month supply paid upfront ($279 to $605), with no month-to-month option
- Its own treatments page lists a different, older price set whose sign-up links lead to 'program not currently available'
- The compounding pharmacy is not named, only 'a licensed US pharmacy'
- Shipped medication can't be refunded, which is up to 3 months of medication at once
- Phone support is advertised but no phone number is published, only email
- Cancellation steps differ between pages: two clicks in the dashboard, or by email or phone
- Brand-new site with no Trustpilot or BBB profile found
Is Vitakey worth it?
Vitakey built its program around one core idea: low-cost compounded semaglutide or tirzepatide if you are fine prepaying for 3 months. It runs $93/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. It's a fairly plain, no-frills entry in the GLP-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
It offers a microdosing option. It also is LegitScript-certified and charges no membership fee.
How much Vitakey actually costs
Compounded semaglutide runs $93–$138/month depending on plan and compounded tirzepatide runs $172–$202/month depending on plan.
That puts Vitakey below the roughly $179 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, altRX runs semaglutide and tirzepatide from $89/month — worth pricing against Vitakey before you commit.
Medications: what Vitakey prescribes
Vitakey prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Vitakey is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $93/month is below the roughly $179 median we track across the category.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Vitakey earns its place on the shortlist mainly on price: at $93/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Vitakey scores best in our breakdown.
Ready to start with Vitakey?
Starting at $93/month. See current pricing and start your free consultation.
Vitakey might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Vitakey review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Vitakey's current pricing
Plans start at $93/month. Start your free consultation to check eligibility and today's price.